Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis
European Heart Journal2021Vol. 43(16), pp. 1582–1593
Citations Over TimeTop 1% of 2021 papers
Mihir A Kelshiker, Henry Seligman, James P. Howard, Haseeb Rahman, Michael Foley, Alexandra N. Nowbar, Christopher Rajkumar, Matthew Shun‐Shin, Yousif Ahmad, Sayan Sen, Rasha Al‐Lamee, Ricardo Petraco, Graham D. Cole, Stephen P. Hoole, Paul Morris, F Rigo, Dárrel P. Francis, Jamil Mayet
Abstract
Reduced coronary flow is strongly associated with increased risk of all-cause mortality and MACE across a wide range of pathological processes. This finding supports recent recommendations that coronary flow should be measured more routinely in clinical practice, to target aggressive vascular risk modification for individuals at higher risk.
Related Papers
- → Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus(2016)45 cited
- → The Prognostic Value of Survivin Expression in Patients with Colorectal Carcinoma: A Meta-analysis(2013)27 cited
- → Survival impact of compliance in extra-perigastric lymphadenectomy for gastric cancer: 20 years of real-world data from a single institution(2022)7 cited
- → A pilot study of high-risk screening for neuronopathic Gaucher disease in Japan(2018)
- → Glucosylsphingosine concentration is the most reliable response-parameter for low-dose ERT in homozygous N370S Gaucher patients(2018)